Literature DB >> 26121197

Inflammasomes: mechanism of action, role in disease, and therapeutics.

Haitao Guo1, Justin B Callaway1, Jenny P-Y Ting2.   

Abstract

The inflammasomes are innate immune system receptors and sensors that regulate the activation of caspase-1 and induce inflammation in response to infectious microbes and molecules derived from host proteins. They have been implicated in a host of inflammatory disorders. Recent developments have greatly enhanced our understanding of the molecular mechanisms by which different inflammasomes are activated. Additionally, increasing evidence in mouse models, supported by human data, strongly implicates an involvement of the inflammasome in the initiation or progression of diseases with a high impact on public health, such as metabolic disorders and neurodegenerative diseases. Finally, recent developments pointing toward promising therapeutics that target inflammasome activity in inflammatory diseases have been reported. This review will focus on these three areas of inflammasome research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26121197      PMCID: PMC4519035          DOI: 10.1038/nm.3893

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  143 in total

Review 1.  Innate immunity in Alzheimer's disease.

Authors:  Michael T Heneka; Douglas T Golenbock; Eicke Latz
Journal:  Nat Immunol       Date:  2015-03       Impact factor: 25.606

2.  Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.

Authors:  Seth L Masters; Aisling Dunne; Shoba L Subramanian; Rebecca L Hull; Gillian M Tannahill; Fiona A Sharp; Christine Becker; Luigi Franchi; Eiji Yoshihara; Zhe Chen; Niamh Mullooly; Lisa A Mielke; James Harris; Rebecca C Coll; Kingston H G Mills; K Hun Mok; Philip Newsholme; Gabriel Nuñez; Junji Yodoi; Steven E Kahn; Ed C Lavelle; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2010-09-12       Impact factor: 25.606

3.  Inflammasome is a central player in the induction of obesity and insulin resistance.

Authors:  Rinke Stienstra; Janna A van Diepen; Cees J Tack; Md Hasan Zaki; Frank L van de Veerdonk; Deshani Perera; Geoffrey A Neale; Guido J Hooiveld; Anneke Hijmans; Irene Vroegrijk; Sjoerd van den Berg; Johannes Romijn; Patrick C N Rensen; Leo A B Joosten; Mihai G Netea; Thirumala-Devi Kanneganti
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

4.  The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity.

Authors:  Rinke Stienstra; Leo A B Joosten; Tim Koenen; Berry van Tits; Janna A van Diepen; Sjoerd A A van den Berg; Patrick C N Rensen; Peter J Voshol; Giamilla Fantuzzi; Anneke Hijmans; Sander Kersten; Michael Müller; Wim B van den Berg; Nico van Rooijen; Martin Wabitsch; Bart-Jan Kullberg; Jos W M van der Meer; Thirumala Kanneganti; Cees J Tack; Mihai G Netea
Journal:  Cell Metab       Date:  2010-12-01       Impact factor: 27.287

5.  Activation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domain.

Authors:  Nicole B Bryan; Andrea Dorfleutner; Yon Rojanasakul; Christian Stehlik
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  Molecular basis for specific recognition of bacterial ligands by NAIP/NLRC4 inflammasomes.

Authors:  Jeannette L Tenthorey; Eric M Kofoed; Matthew D Daugherty; Harmit S Malik; Russell E Vance
Journal:  Mol Cell       Date:  2014-03-20       Impact factor: 17.970

Review 7.  Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.

Authors:  Adilson Guilherme; Joseph V Virbasius; Vishwajeet Puri; Michael P Czech
Journal:  Nat Rev Mol Cell Biol       Date:  2008-05       Impact factor: 94.444

8.  Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation.

Authors:  Hiroe Honda; Yoshinori Nagai; Takayuki Matsunaga; Naoki Okamoto; Yasuharu Watanabe; Koichi Tsuneyama; Hiroaki Hayashi; Isao Fujii; Masashi Ikutani; Yoshikatsu Hirai; Atsushi Muraguchi; Kiyoshi Takatsu
Journal:  J Leukoc Biol       Date:  2014-09-10       Impact factor: 4.962

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

10.  An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.

Authors:  Scott W Canna; Adriana A de Jesus; Sushanth Gouni; Stephen R Brooks; Bernadette Marrero; Yin Liu; Michael A DiMattia; Kristien J M Zaal; Gina A Montealegre Sanchez; Hanna Kim; Dawn Chapelle; Nicole Plass; Yan Huang; Alejandro V Villarino; Angelique Biancotto; Thomas A Fleisher; Joseph A Duncan; John J O'Shea; Susanne Benseler; Alexei Grom; Zuoming Deng; Ronald M Laxer; Raphaela Goldbach-Mansky
Journal:  Nat Genet       Date:  2014-09-14       Impact factor: 38.330

View more
  975 in total

1.  Global transcriptomic changes occur in aged mouse podocytes.

Authors:  Yuliang Wang; Diana G Eng; Natalya V Kaverina; Carol J Loretz; Abbal Koirala; Shreeram Akilesh; Jeffrey W Pippin; Stuart J Shankland
Journal:  Kidney Int       Date:  2020-06-25       Impact factor: 10.612

2.  The inflammasome in fibromyalgia and CRPS: a microglial hypothesis?

Authors:  Mario D Cordero
Journal:  Nat Rev Rheumatol       Date:  2015-09-29       Impact factor: 20.543

3.  High-Intensity Exercise Prevents Disturbances in Lung Inflammatory Cytokines and Antioxidant Defenses Induced by Lipopolysaccharide.

Authors:  Gisele Henrique Cardoso; Débora Melissa Petry; Jéssica Jorge Probst; Luiz Felipe de Souza; Gabriella Ganguilhet; Franciane Bobinski; Adair R S Santos; Daniel Fernandes Martins; Kelly Cattelan Bonorino; Alcir Luiz Dafre; Deborah de C Hizume Kunzler
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

4.  Discovery of N-Cyano-sulfoximineurea Derivatives as Potent and Orally Bioavailable NLRP3 Inflammasome Inhibitors.

Authors:  Sameer Agarwal; Santosh Sasane; Hardik A Shah; Jignesh P Pethani; Prashant Deshmukh; Vismit Vyas; Pravin Iyer; Harsh Bhavsar; Kasinath Viswanathan; Debdutta Bandyopadhyay; Poonam Giri; Jogeswar Mahapatra; Abhijit Chatterjee; Mukul R Jain; Rajiv Sharma
Journal:  ACS Med Chem Lett       Date:  2020-02-27       Impact factor: 4.345

5.  Bile acid analogues are activators of pyrin inflammasome.

Authors:  Irina Alimov; Suchithra Menon; Nadire Cochran; Rob Maher; Qiong Wang; John Alford; John B Concannon; Zinger Yang; Edmund Harrington; Luis Llamas; Alicia Lindeman; Gregory Hoffman; Tim Schuhmann; Carsten Russ; John Reece-Hoyes; Stephen M Canham; Xinming Cai
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

6.  A novel PINK1- and PARK2-dependent protective neuroimmune pathway in lethal sepsis.

Authors:  Rui Kang; Ling Zeng; Yangchun Xie; Zhengwen Yan; Borong Zhou; Lizhi Cao; Daniel J Klionsky; Kevin J Tracey; Jianhua Li; Haichao Wang; Timothy R Billiar; Jianxin Jiang; Daolin Tang
Journal:  Autophagy       Date:  2016-10-18       Impact factor: 16.016

Review 7.  Inflammatory osteolysis: a conspiracy against bone.

Authors:  Gabriel Mbalaviele; Deborah V Novack; Georg Schett; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

Review 8.  Mitochondrial DNA in Sepsis.

Authors:  John S Harrington; Augustine M K Choi; Kiichi Nakahira
Journal:  Curr Opin Crit Care       Date:  2017-08       Impact factor: 3.687

Review 9.  Autophagy in Pulmonary Diseases.

Authors:  Kiichi Nakahira; Maria Angelica Pabon Porras; Augustine M K Choi
Journal:  Am J Respir Crit Care Med       Date:  2016-11-15       Impact factor: 21.405

10.  Scavenging nucleic acid debris to combat autoimmunity and infectious disease.

Authors:  Eda K Holl; Kara L Shumansky; Luke B Borst; Angela D Burnette; Christopher J Sample; Elizabeth A Ramsburg; Bruce A Sullenger
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.